Condensed Unaudited Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ 42,083	$ 22,557
General and administrative	31,758	12,113
Total operating expenses	73,841	34,670
Loss from operations	(73,841)	(34,670)
Interest income, net	3,461	133
Other (expense) income, net	(1,849)	1
Loss before income tax benefit	(72,229)	(34,536)
Income tax benefit	0	0
Net loss	(72,229)	(34,536)
Comprehensive loss	$ (72,099)	$ (34,840)
Net loss per common share:
Basic (in usd per share)	$ (0.53)	$ (0.29)
Diluted (in usd per share)	$ (0.53)	$ (0.29)
Weighted average common shares outstanding:
Basic (in shares)	137,087	118,755
Diluted (in shares)	137,087	118,755